Illumina Global Healthcare Conclave Oncology 2021

Regular price
$10.00
Sale price
$10.00
Regular price
$0
Sold out
Unit price
Quantity must be 1 or more

Illumina Global Healthcare Conclave Oncology 2021

Format:2 videos, size: 4.23 GB

Course Audience: oncologist

Overview:

Illumina is proud to be the platinum sponsor at the Global Healthcare Conclave Oncology Conference that will be held in a hybrid format. The conference will be held at the Royal Adelaide Hospital Auditorium with a live stream for participants from Australia, India, Malaysia and Singapore. Attend our presentation on day 1 to understand how you can enable Comprehensive Genomic Profiling in your laboratory.

Presentation

Date: 19th May 2021, Wednesday
Time: 05:15 pm – 05:30 pm (ACST)
Speakers: Joel Geoghegan

Associate Manager, Sales Specialist (Oncology),

Illumina Asia Pacific Japan
Title: The Future of Cancer Care – Enabling Comprehensive Genomic Profiling in your Laboratory
Biography: Joel Geoghegan leads a team of Illumina Oncology Specialists in the Asia-Pacific region to help drive the adoption of next-generation sequencing technology across the cancer continuum supporting basic cancer research, translational research and oncology testing. His career spans 20+ years of developing and implementing cutting edge genomic technologies in research and clinical settings. In his previous role with SA Pathology (Adelaide, South Australia), he supervised the first lab in Australia to receive ISO13485 accreditation for diagnostic whole exome sequencing, transcriptome sequencing and somatic variant detection.

Before moving to Australia, he was based in Madison, WI, USA as a Product Development Scientist for NimbleGen Systems (later Roche NimbleGen through acquisition) overseeing the launch of numerous high-density array and hybridisation-based enrichment products. His career began with 2 fellowships at the National Cancer Institute (NCI) in Bethesda, MA, USA using some of the first custom microarrays to study gene expression changes associated with the progression of cancers. He later transitioned to a new role in the Advanced Technology Center for the NCI manufacturing, developing and training researchers how to use microarrays for gene expression and comparative genomic hybridization. His focus and expertise in new technologies has led to numerous collaborations with key opinion leaders around the world resulting in publications in Nature Genetics, Nature Methods, PNAS and Human Mutation to name a few.

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

May 19 (Video MP4 Format)

May 20 (Video MP4 Format)

* Detail: no information

Go to full site